FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

CUSIP: 31189P102

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
122,342,805
Total 13F shares
122,159,363
Share change
-920,692
Total reported value
$400,671,566
Put/Call ratio
93%
Price per share
$3.28
Number of holders
176
Value change
-$37,762,295
Number of buys
90
Number of sells
70

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Redmile Group, LLC
13F
Company
11%
13,169,057
$96,660,878 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
8.1%
9,911,007
$72,746,792 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
7.4%
9,099,951
$66,793,642 31 Mar 2024
13F
Boxer Capital, LLC
13F
Company
6.7%
8,215,910
$60,304,779 31 Mar 2024
13F
STATE STREET CORP
13F
Company
6.6%
8,036,669
$58,989,150 31 Mar 2024
13F
Deep Track Capital, LP
13F
Company
4.6%
5,572,607
$40,902,935 31 Mar 2024
13F
Bellevue Group AG
13F
Company
4%
4,839,779
$35,523,978 31 Mar 2024
13F
JOHNSON & JOHNSON
13F
Company
2.8%
3,379,064
$24,802,330 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
2.6%
3,131,526
$22,985,401 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
2.5%
3,065,789
$22,502,891 31 Mar 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
2.2%
2,730,966
$20,045,290 31 Mar 2024
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
2.1%
2,562,852
$18,811,334 31 Mar 2024
13F
Assenagon Asset Management S.A.
13F
Company
2.1%
2,548,304
$18,704,551 31 Mar 2024
13F
Holocene Advisors, LP
13F
Company
2.1%
2,527,747
$18,553,663 31 Mar 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.8%
2,190,408
$16,077,595 31 Mar 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.7%
2,140,000
$15,707,600 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.6%
2,012,258
$14,769,973 31 Mar 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
1.6%
1,999,822
$14,678,693 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.6%
1,919,776
$14,091,156 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.6%
1,905,983
$13,991,921 31 Mar 2024
13F
Woodline Partners LP
13F
Company
1.5%
1,892,002
$13,887,295 31 Mar 2024
13F
BAKER BROS. ADVISORS LP
13F
Company
1.5%
1,818,181
$13,345,449 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
1.4%
1,759,321
$12,913,416 31 Mar 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1.4%
1,714,124
$12,581,000 31 Mar 2024
13F
Point72 Asset Management, L.P.
13F
Company
1.3%
1,584,300
$11,628,762 31 Mar 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
1.2%
1,437,700
$10,552,718 31 Mar 2024
13F
ORBIMED ADVISORS LLC
13F
Company
1.1%
1,355,352
$9,948,284 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.87%
1,063,179
$7,803,734 31 Mar 2024
13F
FEDERATED HERMES, INC.
13F
Company
0.82%
1,007,378
$7,394,155 31 Mar 2024
13F
Invesco Ltd.
13F
Company
0.79%
965,431
$7,086,263 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.78%
956,331
$7,019,470 31 Mar 2024
13F
SUPERSTRING CAPITAL MANAGEMENT LP
13F
Company
0.75%
920,476
$6,756,294 31 Mar 2024
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.72%
886,925
$6,510,028 31 Mar 2024
13F
Soleus Capital Management, L.P.
13F
Company
0.71%
870,000
$6,385,800 31 Mar 2024
13F
Vestal Point Capital, LP
13F
Company
0.65%
800,000
$5,872,000 31 Mar 2024
13F
Rafferty Asset Management, LLC
13F
Company
0.6%
729,657
$5,355,682 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.59%
716,052
$5,255,822 31 Mar 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.57%
700,000
$5,138,000 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.51%
623,058
$4,573,246 31 Mar 2024
13F
Octagon Capital Advisors LP
13F
Company
0.43%
520,800
$3,822,672 31 Mar 2024
13F
GCM Grosvenor Holdings, LLC
13F
Company
0.41%
495,916
$3,640,023 31 Mar 2024
13F
Hudson Bay Capital Management LP
13F
Company
0.38%
460,000
$3,376,400 31 Mar 2024
13F
UBS Group AG
13F
Company
0.36%
444,050
$3,259,327 31 Mar 2024
13F
J. Scott Wolchko
3/4/5
President and CEO, Director
mixed-class rows
871,248
mixed-class rows
$2,987,354 01 Feb 2024
PRUDENTIAL FINANCIAL INC
13F
Company
0.31%
383,201
$2,812,695 31 Mar 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.31%
378,608
$2,778,983 31 Mar 2024
13F
Artal Group S.A.
13F
Company
0.29%
360,311
$2,644,683 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.28%
345,437
$2,535,508 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.27%
324,243
$2,379,945 31 Mar 2024
13F
Monaco Asset Management SAM
13F
Company
0.26%
316,805
$2,325,349 31 Mar 2024
13F

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2024

As of 30 Jun 2024, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 176 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,159,363 shares. The largest 10 holders included Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., Boxer Capital, LLC, Deep Track Capital, LP, STATE STREET CORP, Bellevue Group AG, CITADEL ADVISORS LLC, D. E. Shaw & Co., Inc., and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 177 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
160
Q2 2024 holders
176
Holder diff
16
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .